Literature DB >> 508298

Metabolism of glucose in hyper- and hypo-thyroid rats in vivo. Minor role of endogenous insulin in thyroid-dependent changes in glucose turnover.

F Okajima, M Ui.   

Abstract

1. Rates and rate coefficients of glucose utilization and replacement (glucose turnover) as well as its recycling were determined in rats by using [U-14C]- and [2-3H]-, [3-3H]- or [6-3H]-glucose. 2. In euthyroid rats, the blood concentration of glucose was 1.5 times and its turnover rate was 2 times as high in the fed state as in the starved state; consequently the rate coefficient, a measure of the capacity of rats to utilize blood glucose, was also higher in the former than in the latter. 3. Induction of mild diabetes by streptozotocin exerted little influence on the content and turnover of blood glucose in the starved state, whereas it caused hyperglycaemia and a decrease in the rate coefficient after feeding. 4. Induction of hyperthyroidism caused increases in rates and rate coefficients of glucose turnover to substantially the same extent whether or not the plasma concentration of insulin was lowered by treatment with streptozotocin or injection with anti-insulin serum. 5. It is concluded that thyroid hormones are capable of enhancing glucose turnover in the starved state independently of endogenous insulin, which plays a significant role in increasing glucose utilization in the fed state.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508298      PMCID: PMC1161339          DOI: 10.1042/bj1820577

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  Spontaneous recovery from streptozotocin-induced diabetes in rats pretreated with pertussis vaccine or hydrocortisone.

Authors:  T Katada; M Ui
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

2.  Thyroid function and insulin secretion from the perfused pancreas in the rat.

Authors:  S Lenzen; H G Joost; A Hasselblatt
Journal:  Endocrinology       Date:  1976-07       Impact factor: 4.736

3.  Abnormalities of carbohydrate metabolism in experimental and clinical hyperthyroidism: studies on plasma insulin and on the A- and B-chains of insulin.

Authors:  A Orsetti; F Collard; C Jaffiol
Journal:  Acta Diabetol Lat       Date:  1974 Nov-Dec

4.  Glucose turnover in the post-absorptive rat and the effects of halothane anaesthesia.

Authors:  D F Heath; K N Frayn; J G Rose
Journal:  Biochem J       Date:  1977-03-15       Impact factor: 3.857

5.  Rates of glucose utilization and glucogenesis in rats in the basal state induced by halothane anaesthesia.

Authors:  D F Heath; K N Frayn; J G Rose
Journal:  Biochem J       Date:  1977-03-15       Impact factor: 3.857

6.  Imparied plasma insulin response to arginine in hyperthyroidism. Important role of the rise of blood glucose in the second phase of insulin release induced by argiinine.

Authors:  H Imura; Y Seino; M Ikeda; T Taminato; Y Miyamoto
Journal:  Diabetes       Date:  1976-10       Impact factor: 9.461

7.  Perfusion of the pancreas isolated from pertussis-sensitized rats: potentiation of insulin secretory responses due to beta-adrenergic stimulation.

Authors:  T Katada; M Ui
Journal:  Endocrinology       Date:  1977-10       Impact factor: 4.736

8.  Attenuation of epinephrine-induced increase in liver cyclic AMP by endogeneous insulin in vivo.

Authors:  H Shikama; M Ui
Journal:  Biochim Biophys Acta       Date:  1976-09-24

9.  Metabolism of glucose in hyper- and hypo-thyroid rats in vivo. Glucose-turnover values and futile-cycle activities obtained with 14C- and 3H-labelled glucose.

Authors:  F Okajima; M Ui
Journal:  Biochem J       Date:  1979-08-15       Impact factor: 3.857

10.  Metabolism of glucose in hyper- and hypo-thyroid rats in vivo. Relation of catecholamine actions to thyroid activity in controlling glucose turnover.

Authors:  F Okajima; M Ui
Journal:  Biochem J       Date:  1979-08-15       Impact factor: 3.857

View more
  9 in total

1.  Glucoregulatory function of glucagon in hypo-, eu- and hyperthyroid miniature pigs.

Authors:  M J Müller; P E Mitchinson; U Paschen; H J Seitz
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

2.  Glucose utilization by skeletal muscles in vivo in experimental hyperthyroidism in the rat.

Authors:  M C Sugden; Y L Liu; M J Holness
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

Review 3.  Thyroid hormone action on intermediary metabolism. Part I: respiration, thermogenesis and carbohydrate metabolism.

Authors:  M J Müller; H J Seitz
Journal:  Klin Wochenschr       Date:  1984-01-02

4.  Mechanisms regulating cardiac fuel selection in hyperthyroidism.

Authors:  M C Sugden; M J Holness; Y L Liu; D M Smith; L G Fryer; Y T Kruszynska
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

5.  13C NMR study of gluconeogenesis from labeled alanine in hepatocytes from euthyroid and hyperthyroid rats.

Authors:  S M Cohen; P Glynn; R G Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

6.  Metabolism of glucose in hyper- and hypo-thyroid rats in vivo. Glucose-turnover values and futile-cycle activities obtained with 14C- and 3H-labelled glucose.

Authors:  F Okajima; M Ui
Journal:  Biochem J       Date:  1979-08-15       Impact factor: 3.857

7.  Metabolism of glucose in hyper- and hypo-thyroid rats in vivo. Relation of catecholamine actions to thyroid activity in controlling glucose turnover.

Authors:  F Okajima; M Ui
Journal:  Biochem J       Date:  1979-08-15       Impact factor: 3.857

8.  The effect of thyroid hormones on blood insulin level and metabolic parameters in diabetic rats.

Authors:  T Szkudelski; W Michalski; K Szkudelska
Journal:  J Physiol Biochem       Date:  2003-06       Impact factor: 4.158

9.  Exposure to perfluoroundecanoic acid (PFUnDA) accelerates insulitis development in a mouse model of type 1 diabetes.

Authors:  Johanna Bodin; Else-Carin Groeng; Monica Andreassen; Hubert Dirven; Unni Cecilie Nygaard
Journal:  Toxicol Rep       Date:  2016-08-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.